HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage.

Abstract
Severe injury deranges immune function and increases the risk of sepsis and multiple organ failure. Kupffer cells play a major role in mediating posttraumatic immune responses, in part via different Toll-like receptors (TLR). Although mitogen-activated protein kinases (MAPK) are key elements in the TLR signaling pathway, it remains unclear whether the activation of different MAPK are TLR specific. Male C3H/HeN mice underwent midline laparotomy (i.e., soft tissue injury), hemorrhagic shock (MAP approximately 35 mm Hg for 90 min), and resuscitation. Kupffer cells were isolated 2 h thereafter, lysed and immunoblotted with antibodies to p38, ERK1/2, or JNK proteins. In addition, cells were preincubated with specific inhibitors of p38, ERK1/2, or JNK MAPK followed by stimulation with the TLR2 agonist, zymosan; the TLR4 agonist, LPS; or the TLR9 agonist, CpG DNA. Cytokine (TNF-alpha, interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and KC) production was determined by cytometric bead array after 24 h in culture. MAPK activity as well as TNF-alpha, MCP-1, and KC production by Kupffer cells were significantly increased following trauma-hemorrhage. TLR4 activation by LPS stimulation increased the levels of all measured cytokines. CpG-stimulated TLR9 signaling increased TNF-alpha and IL-6 levels; however, it had no effect on chemokine production. Selective MAPK inhibition demonstrated that chemokine production was mediated via p38 and JNK MAPK activation in TLR2, -4, and -9 signaling. In contrast, TNF-alpha and IL-6 production was differentially regulated by MAPK depending on the TLR pathway stimulated. Thus, Kupffer cell TLR signaling employs different MAPK pathways in eliciting cytokine and chemokine responses following trauma-hemorrhage.
AuthorsBjoern M Thobe, Michael Frink, Frank Hildebrand, Martin G Schwacha, William J Hubbard, Mashkoor A Choudhry, Irshad H Chaudry
JournalJournal of cellular physiology (J Cell Physiol) Vol. 210 Issue 3 Pg. 667-75 (Mar 2007) ISSN: 0021-9541 [Print] United States
PMID17117477 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright 2006 Wiley-Liss, Inc.
Chemical References
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Interleukin-6
  • Lipopolysaccharides
  • Tlr2 protein, mouse
  • Tlr4 protein, mouse
  • Tlr9 protein, mouse
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Toll-Like Receptor 9
  • Tumor Necrosis Factor-alpha
  • Zymosan
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Cells, Cultured
  • Chemokine CCL2 (metabolism)
  • Hemorrhage (pathology, physiopathology)
  • Interleukin-6 (metabolism)
  • JNK Mitogen-Activated Protein Kinases (physiology)
  • Kupffer Cells (pathology, physiology)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Mice
  • Mice, Inbred C3H
  • Mitogen-Activated Protein Kinase 3 (physiology)
  • Mitogen-Activated Protein Kinases (metabolism)
  • Signal Transduction (physiology)
  • Toll-Like Receptor 2 (agonists, physiology)
  • Toll-Like Receptor 4 (agonists, physiology)
  • Toll-Like Receptor 9 (agonists, physiology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Wounds and Injuries (pathology, physiopathology)
  • Zymosan (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: